For patients diagnosed with multiple myeloma, the future is more promising than ever. Survival has more than tripled in the last 40 years. That’s due, in large part, to therapies that have emerged in the past decade, including those LLS funding has helped advance: Velcade ®, Kyprolis ®, Thalimid®, Revlimid®, and Pomalyst®.
March is Myeloma Awareness Month, providing an opportunity to shine a spotlight on the many advances in treatments for multiple myeloma and the urgent need for continued research.
LLS has a strong commitment to advancing therapies for myeloma. Last year alone, LLS committed $9.7 million to myeloma research, funding 24 grants and four Therapy Acceleration Program (TAP) projects. Since 2008, LLS has invested more than $32 million to fund myeloma research.
LLS’s myeloma funding supports scientific research from understanding the disease mechanisms to discovering novel potential therapies and supporting clinical. Two of our largest grants udner our Specialized Centers of Research (SCOR) program are currently focused on myeloma research. TAP supports a team of researchers at Johns Hopkins conducting a Phase 2 clinical trial testing a novel immunotherapy approach using specially trained immune T cells to track and kill myeloma cells, and a small biotechnology company in Boston developing a novel drug to treat myeloma.
In addition to supporting research, LLS is committed to providing free information and support services to patients and their families. The Information Resource Center provides access to information specialists who can assist patients with financial and social challenges and give accurate, up-to-date disease and treatment information. LLS also offers family support groups, online chats and free information publications and education programs, including monthly enewsletters with the latest news, research updates, clinical trials and events sponsored by LLS.
Our goal is a world without blood cancers – including multiple myeloma!
To see the impact of the work we've done to help patients with myeloma, watch this inspiring video. Click here to view.
Help LLS raise awareness druing this month. Visit our Facebook page, where we will be using Myeloma Mondays to highlight facts about this disease and how you can help bring myeloma to an end.
(photo, Andy, myeloma survivor)